Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandeep Dutta

Showing results (41-50 of 114) with videos related to

Pageof 12
Sort By:
The Journal of Pharmacy and Pharmacology|May 15, 2002
Multiple dose pharmacokinetics of fiduxosin under fasting conditions in healthy elderly male subjectsSandeep Dutta, Yiming Zhang, Daniel J Daszkowski, et al.
Clinical Pharmacology : Advances and Applications|August 18, 2020
Dose Regimen Rationale for Panitumumab in Cancer Patients: To Be Based on Body Weight or NotMichael Z Liao, Marloes Berkhout, Hans Prenen, et al.
Clinical Drug Investigation|May 8, 2016
Exposure-Efficacy Analyses of Ombitasvir, Paritaprevir/Ritonavir with Dasabuvir ± Ribavirin in HCV Genotype 1-Infected PatientsAmit Khatri, Sven Mensing, Thomas Podsadecki, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 23, 2013
Effect of ketoconazole on the pharmacokinetics of the 11β-hydroxysteroid dehydrogenase type 1 inhibitor ABT-384 and its two active metabolites in healthy volunteers: population analysis of data from a drug-drug interaction studyGuohua An, Wei Liu, David A Katz, et al.
British Journal of Clinical Pharmacology|November 13, 2013
The H3 antagonist ABT-288 is tolerated at significantly higher exposures in subjects with schizophrenia than in healthy volunteersAhmed A Othman, George Haig, Hana Florian, et al.
Physics in Medicine and Biology|February 10, 2006
A three-dimensional-weighted cone beam filtered backprojection (CB-FBP) algorithm for image reconstruction in volumetric CT-helical scanningXiangyang Tang, Jiang Hsieh, Roy A Nilsen, et al.
European Journal of Drug Metabolism and Pharmacokinetics|July 9, 2017
Pharmacokinetic Interactions and Safety of Coadministration of Glecaprevir and Pibrentasvir in Healthy VolunteersChih-Wei Lin, Sandeep Dutta, Weihan Zhao, et al.
British Journal of Clinical Pharmacology|September 29, 2012
Safety, tolerability and pharmacokinetics of the histamine H3 receptor antagonist, ABT-288, in healthy young adults and elderly volunteersAhmed A Othman, George Haig, Hana Florian, et al.
Clinical Pharmacology and Therapeutics|September 25, 2023
A Mechanistic Physiologically-Based Pharmacokinetic Platform Model to Guide Adult and Pediatric Intravenous and Subcutaneous Dosing for Bispecific T Cell EngagersXinwen Zhang, Annie Lumen, Hansen Wong, et al.
The AAPS Journal|January 13, 2025
Population Pharmacokinetics of Sotorasib in Healthy Subjects and Advanced Solid Tumor Patients Harboring a KRAS<sup>G12C</sup> Mutation from Phase 1 and Phase 2 StudiesMario Nagase, Brett Houk, Irene Vuu, et al.
Pageof 12

Showing results (41-50 of 114) with videos related to

Sort By:
Pageof 12
The Journal of Pharmacy and Pharmacology|May 15, 2002
Multiple dose pharmacokinetics of fiduxosin under fasting conditions in healthy elderly male subjectsSandeep Dutta, Yiming Zhang, Daniel J Daszkowski, et al.
Clinical Pharmacology : Advances and Applications|August 18, 2020
Dose Regimen Rationale for Panitumumab in Cancer Patients: To Be Based on Body Weight or NotMichael Z Liao, Marloes Berkhout, Hans Prenen, et al.
Clinical Drug Investigation|May 8, 2016
Exposure-Efficacy Analyses of Ombitasvir, Paritaprevir/Ritonavir with Dasabuvir ± Ribavirin in HCV Genotype 1-Infected PatientsAmit Khatri, Sven Mensing, Thomas Podsadecki, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 23, 2013
Effect of ketoconazole on the pharmacokinetics of the 11β-hydroxysteroid dehydrogenase type 1 inhibitor ABT-384 and its two active metabolites in healthy volunteers: population analysis of data from a drug-drug interaction studyGuohua An, Wei Liu, David A Katz, et al.
British Journal of Clinical Pharmacology|November 13, 2013
The H3 antagonist ABT-288 is tolerated at significantly higher exposures in subjects with schizophrenia than in healthy volunteersAhmed A Othman, George Haig, Hana Florian, et al.
Physics in Medicine and Biology|February 10, 2006
A three-dimensional-weighted cone beam filtered backprojection (CB-FBP) algorithm for image reconstruction in volumetric CT-helical scanningXiangyang Tang, Jiang Hsieh, Roy A Nilsen, et al.
European Journal of Drug Metabolism and Pharmacokinetics|July 9, 2017
Pharmacokinetic Interactions and Safety of Coadministration of Glecaprevir and Pibrentasvir in Healthy VolunteersChih-Wei Lin, Sandeep Dutta, Weihan Zhao, et al.
British Journal of Clinical Pharmacology|September 29, 2012
Safety, tolerability and pharmacokinetics of the histamine H3 receptor antagonist, ABT-288, in healthy young adults and elderly volunteersAhmed A Othman, George Haig, Hana Florian, et al.
Clinical Pharmacology and Therapeutics|September 25, 2023
A Mechanistic Physiologically-Based Pharmacokinetic Platform Model to Guide Adult and Pediatric Intravenous and Subcutaneous Dosing for Bispecific T Cell EngagersXinwen Zhang, Annie Lumen, Hansen Wong, et al.
The AAPS Journal|January 13, 2025
Population Pharmacokinetics of Sotorasib in Healthy Subjects and Advanced Solid Tumor Patients Harboring a KRAS<sup>G12C</sup> Mutation from Phase 1 and Phase 2 StudiesMario Nagase, Brett Houk, Irene Vuu, et al.
Pageof 12